Medelis Adds Marketing MO Co-founder Jim Sagar to Board of Directors

Share Article

Jim Sagar, co-founder and CEO of Marketing MO and Medelis co-founder, to join the Medelis Board of Directors

Medelis has played an integral role in the development of many important oncology drugs since its inception, and I look forward to contributing to the future direction and growth of the company.

Medelis, Inc. today announced that Jim Sagar, CEO of privately-held Moderandi Inc., the creator of the Marketing MO planning and management app and its B2B virtual marketing team, and co-founder of Medelis, has been appointed to the company’s board of directors.

“Jim brings a tremendous breadth and depth of marketing and sales experience, from strategic marketing to inbound digital marketing to sales management, along with the insights that come from managing a $25 million dollar company and numerous startups,” said Larry Flanagan, Medelis’ CEO and chairman of the board. “He will be a great addition to our board as the company enters its next phase of growth.”

Sagar currently serves as CEO of Marketing MO, a privately-held company located in Scottsdale, Arizona, whose products and services guide small to midsize companies through positioning and brand strategies and the execution of go-to-market campaigns. Sagar was a co-founder of Medelis in 2003 and has provided Marketing MO’s Outsourced VP of Marketing service to Medelis since 2012.

“I am honored to join the Medelis board and work with this exceptional team,” said Sagar. “Medelis has played an integral role in the development of many important oncology drugs since its inception, and I look forward to contributing to the future direction and growth of the company.”

Sagar received bachelors’ degrees in economics and communications from the University of Michigan.

Medelis is a full-service oncology CRO focused on phase I through phase III oncology trials in North America and Europe.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Natalie
Medelis
+1 480-445-9141
Email >
@oncologycro
since: 06/2008
Follow >
Medelis, Inc.

Visit website